Reappraisal of role of angiotensin receptor blockers in cardiovascular protection
C Venkata S RamTexas Blood Pressure Institute, Clinical Research Institute of Dallas Nephrology Associates; and Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USAAbstract: Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin recept...
Main Author: | Ram CV |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-05-01
|
Series: | Vascular Health and Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/reappraisal-of-role-of-angiotensin-receptor-blockers-in-cardiovascular-peer-reviewed-article-VHRM |
Similar Items
-
Cardiovascular outcomes with angiotensin II receptor blockers: clinical implications of recent trials
by: Baumhäkel M, et al.
Published: (2011-06-01) -
Management of hypertension: Insights into prescribing behavior with focus on angiotensin receptor blockers
by: S Ramakrishnan, et al.
Published: (2017-01-01) -
ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2017-07-01) -
Angiotensin receptor blockers: rational prescription tailored to the cardiovascular risk and comorbidities
by: V. I. Podzolkov, et al.
Published: (2018-12-01) -
Critical review of cancer risk associated with angiotensin receptor blocker therapy
by: Waeber B, et al.
Published: (2011-12-01)